Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Iridex Corp (IRIX)

Iridex Corp (IRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 29,945
  • Shares Outstanding, K 16,636
  • Annual Sales, $ 51,870 K
  • Annual Income, $ -9,570 K
  • EBIT $ -11 M
  • EBITDA $ -10 M
  • 60-Month Beta 0.80
  • Price/Sales 0.55
  • Price/Cash Flow N/A
  • Price/Book 10.83

Options Overview Details

View History
  • Implied Volatility 160.42% ( -1.15%)
  • Historical Volatility 96.78%
  • IV Percentile 89%
  • IV Rank 20.96%
  • IV High 665.97% on 09/24/24
  • IV Low 26.37% on 10/15/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 43
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 1,137
  • Open Int (30-Day) 943

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2717 +39.18%
on 11/06/24
1.9400 -8.76%
on 11/13/24
+0.2500 (+16.45%)
since 10/25/24
3-Month
1.2717 +39.18%
on 11/06/24
2.0400 -13.24%
on 09/16/24
-0.1800 (-9.23%)
since 08/26/24
52-Week
1.2717 +39.18%
on 11/06/24
3.6500 -51.51%
on 04/09/24
-0.2300 (-11.50%)
since 11/24/23

Most Recent Stories

More News
Iridex Corporation Confirms Adoption of Local Coverage Determination L37531 for Micro-Invasive Glaucoma Surgery

Iridex confirms effective adoption of LCD L37531, enhancing reimbursement for its laser glaucoma treatments.Quiver AI SummaryIridex Corporation announced that the Local Coverage Determination (LCD) L37531...

IRIX : 1.7700 (unch)
Iridex Comments on Changing Glaucoma Reimbursement Landscape

IRIX : 1.7700 (unch)
Iridex: Q3 Earnings Snapshot

Iridex: Q3 Earnings Snapshot

IRIX : 1.7700 (unch)
Iridex Reports Third Quarter 2024 Financial Results

IRIX : 1.7700 (unch)
Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024

IRIX : 1.7700 (unch)
RMTI Stock Rises 138% in Q3: What Should You Do Ahead of Earnings?

Rockwell Medical RMTI is scheduled to report third-quarter 2024 results on Nov. 11, before the opening bell.In the last reported quarter, the company’s adjusted earnings of 1 cent exceeded the Zacks...

RMTI : 2.25 (-2.60%)
IRIX : 1.7700 (unch)
EDAP : 2.37 (-4.05%)
Rockwell Medical on Expansion Spree: Should You Buy the Stock Now?

Good times continue for Rockwell Medical RMTI stock. Back-to-back big announcements over the recent months, like the company’s new launches for home hemodialysis, a multi-million-dollar distribution...

RMTI : 2.25 (-2.60%)
IRIX : 1.7700 (unch)
EDAP : 2.37 (-4.05%)
Iridex Appoints Patrick Mercer as Chief Executive Officer

IRIX : 1.7700 (unch)
Rockwell Medical Stock Surges 108.5% YTD: Should You Snap it Up Now?

Rockwell Medical RMTI delivered an impressive performance through 2024, with its stock witnessing more than 108% year-to-date surge, outperforming the 15.5% rise of the industry and the benchmark’s 18.1%...

EDAP : 2.37 (-4.05%)
IRIX : 1.7700 (unch)
RMTI : 2.25 (-2.60%)
Iridex: Q2 Earnings Snapshot

Iridex: Q2 Earnings Snapshot

IRIX : 1.7700 (unch)

Business Summary

IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors....

See More

Key Turning Points

3rd Resistance Point 1.9400
2nd Resistance Point 1.8900
1st Resistance Point 1.8300
Last Price 1.7700
1st Support Level 1.7200
2nd Support Level 1.6700
3rd Support Level 1.6100

See More

52-Week High 3.6500
Fibonacci 61.8% 2.7415
Fibonacci 50% 2.4609
Fibonacci 38.2% 2.1802
Last Price 1.7700
52-Week Low 1.2717

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar